Health
US FDA approves first treatment for severe frostbite
The US Food and Drug Administration on Wednesday approved Eicos Sciences’ injection, making it the first-ever treatment for severe frostbite in adults. The drug, which
Cancer testing company Freenome raises $254m in new funding
Blood test developer Freenome said Thursday it has raised $254 million in a new round of funding led by Swiss drugmaker Roche to develop tests
Cholera vaccine stocks ’empty’ due to rising incidence of disease
The emergency global stockpile of cholera vaccine is empty and all available doses for this month have already been distributed to countries battling major outbreaks,
U.S. has ‘about 18 months’ to create bird flu vaccine
The U.S. Department of Agriculture has “about 18 months” to create a vaccine for the current strain of bird flu and develop a process for
Britain sees the launch of weight loss drug Lilly Mounjaro
Eli Lilly’s Munjaro will be launched in the UK this week, two pharmacy companies said on Wednesday, making the UK the fourth European country to
The U.S. CDC and Prevention plans to do away with the five-day isolation from COVID
The U.S. Centers for Disease Control and Prevention plans to drop its five-day COVID-19 isolation recommendations under new guidance planned by the agency, the Washington
Eli Lilly BioAge partner Eli Lilly BioAge has raised $170m to treat obesity
BioAge Labs, a biotech startup partnering with Eli Lilly for a trial of its obesity treatment, said Tuesday it has raised $170 million in its
Pharmaceutical group’s lawsuit over Medicare drug pricing programme dismissed
A federal judge on Monday dismissed a lawsuit by a major pharmaceutical industry trade association challenging a new programme that allows Medicare to negotiate prices
Novo Nordisk’s controlling shareholder plans to invest about $35bn by 2030
Novo Holdings, the controlling shareholder of Danish obesity drug maker Novo Nordisk plans to invest about $35bn by 2030, Chief Executive Kasim Kutai told Reuters
Weight loss medications linked to benefits after hip replacement
New diabetes and weight-loss drugs may benefit hip replacement patients without increasing the risk of complications, according to preliminary data released Monday at a large